Interestingly with regard to cancer biology and for therapy-related facets, a role for IVNS1ABP in MYC-associated pathways has been reported [32–34] and a certain degree of association between sensitivity to bromodomain inhibitors and enhanced MYC-signaling has also been described [35–37]. The gene discussed is MYC; the disease is cancer.